AMIKACIN SULFATE INJECTION, USP, 1 gram/4 mL (250 mg/ml), 4 mL vial, Rx only, Mf Supply Disruption — Heritage Pharmaceuticals, Inc
AMIKACIN SULFATE INJECTION, USP, 1 gram/4 mL (250 mg/ml), 4 mL vial, Rx only, Mf Supply Disruption — Heritage Pharmaceuticals, Inc is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: AMIKACIN SULFATE INJECTION, USP, 1 gram/4 mL (250 mg/ml), 4 mL vial, Rx only, Mf; Manufacturer: Herit
| Drug name | AMIKACIN SULFATE INJECTION, USP, 1 gram/4 mL (250 mg/ml), 4 mL vial, Rx only, Mf |
|---|---|
| Manufacturer | Heritage Pharmaceuticals, Inc. |
| Recall/Disruption reason | Non-Sterility:Microbial growth detected in sub lot of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorpe |
| Risk classification | High Risk — Serious Health Hazard |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-1398-2019 |
| Initiation date | 20190521 |
| Quantity affected | 14,960 4 mL vials |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →